Benzinga's Top Upgrades, Downgrades For May 12, 2017

Top Upgrades

• Analysts at Morgan Stanley upgraded Visteon Corp VC from Equal-Weight to Overweight. Visteon shares rose 0.01 percent to close at $101.76 on Thursday.
• Analysts at Bank of America upgraded Scorpio Tankers Inc. STNG from Underperform to Buy. Scorpio Tankers shares gained 6.67 percent to $4.48 in pre-market trading.
• Analysts at Goldman Sachs upgraded Tiffany & Co. TIF from Neutral to Buy. Tiffany shares gained 1.08 percent to $93.01 in pre-market trading.
• Analysts at Piper Jaffray upgraded Hancock Holding Company HBHC from Neutral to Overweight. Hancock Holding shares dropped 1.77 percent to close at $47.05 on Thursday.
• JP Morgan upgraded Chemours Co CC from Neutral to Overweight. Chemours shares slipped 0.97 percent to close at $41.88 on Thursday.
• Loop Capital upgraded Bed Bath & Beyond Inc. BBBY from Sell to Hold. Bed Bath & Beyond shares fell 2.66 percent to close at $36.66 on Thursday.
• MKM Partners upgraded Ambac Financial Group, Inc. AMBC from Sell to Neutral. Ambac Financial shares fell 4.20 percent to close at $17.34 on Thursday.
• Cantor Fitzgerald upgraded Trade Desk Inc TTD from Neutral to Overweight. Trade Desk shares climbed 21.6 percent to $48.51 in pre-market trading.

Top Downgrades

• Deutsche Bank downgraded General Electric Company GE from Hold to Sell. General Electric shares dropped 1.45 percent to $28.45 in pre-market trading.
• Morgan Stanley downgraded Castlight Health Inc CSLT from Equal-Weight to Underweight. Castlight Health shares fell 10.23 percent to $3.95 in pre-market trading.
• Citigroup downgraded Dimension Therapeutics Inc DMTX from Buy to Neutral. Dimension Therapeutics shares rose 0.74 percent to $1.36 in pre-market trading.
• Craig-Hallum downgraded Teladoc Inc TDOC from Buy to Hold. Teladoc shares dropped 1.18 percent to $29.35 in pre-market trading.
• Piper Jaffray downgraded Arcadia Biosciences Inc RKDA from Overweight to Neutral. Arcadia Biosciences shares rose 1.27 percent to close at $0.800 on Thursday.
• William Blair downgraded Akari Therapeutics PLC (ADR) AKTX from Outperform to Market Perform. Akari Therapeutics shares fell 19.6 percent to $9.24 in pre-market trading.
• Credit Suisse downgraded Bright Horizons Family Solutions Inc BFAM from Outperform to Neutral. Bright Horizons Family shares dropped 2.43 percent to close at $78.65 on Thursday.
• Analysts at Maxim Group downgraded Syneron Medical Ltd. ELOS from Buy to Hold. Syneron Medical shares closed at $10.85 on Thursday.

Top Initiations

• Analysts at Argus initiated coverage of Quest Diagnostics Inc DGX with a Hold rating. The price target for Quest Diagnostics is set to $102. Quest Diagnostics shares closed at $107.41 on Thursday.
• Analysts at Wells Fargo initiated coverage on The Ultimate Software Group, Inc. ULTI with an Outperform rating. The price target for Ultimate Software is set to $240. Ultimate Software shares closed at $209.40 on Thursday.
• Oppenheimer initiated coverage of Incyte Corporation INCY with a Perform rating. The price target for Incyte is set to $125. Incyte shares closed at $116.43 on Thursday.
• Analysts at Piper Jaffray initiated coverage on First Foundation Inc FFWM with a Neutral rating. The price target for First Foundation is set to $18. First Foundation shares closed at $16.07 on Thursday.
• Goldman Sachs initiated coverage on Orion Engineered Carbons SA OEC with a Neutral rating. The price target for Orion Engineered Carbons is set to $21. Orion Engineered Carbons shares closed at $18.55 on Thursday.
• Analysts at Wells Fargo initiated coverage on Paycom Software Inc PAYC with an Outperform rating. The price target for Paycom Software is set to $75. Paycom Software shares closed at $64.08 on Thursday.
• Wells Fargo initiated coverage on Paylocity Holding Corp PCTY with an Outperform rating. Paylocity shares closed at $43.52 on Thursday.